Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001437749-23-020154
Filing Date
2023-07-18
Accepted
2023-07-18 16:13:00
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM 424B5 govx20230717_424b5.htm 424B5 451834
2 govx20210122_s3img001.jpg GRAPHIC 7891
3 govx20210122_s3img002.jpg GRAPHIC 8956
4 govx20210122_s3img003.gif GRAPHIC 13890
5 govx20230717_424b5img001.jpg GRAPHIC 6659
6 govx20230717_424b5img002.jpg GRAPHIC 6659
  Complete submission text file 0001437749-23-020154.txt   514484
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-252437 | Film No.: 231094389
SIC: 2834 Pharmaceutical Preparations